News

Find out more about how Echo Health Ventures and its portfolio companies are transforming health care.

Optura secures $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures to scale its ROAI™ platform

Optura, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced a $17.5M Series A led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners and HC9 Ventures.

Read more

Echo Health Ventures releases 2025 Impact Report

Read our 2025 Impact Report to learn how Echo, alongside our industry partners, drove sustainable impact in health care over the last year.

Read more

Global Corporate Venturing honors Echo’s Troy Arnold as an Emerging Leader

Global Corporate Venturing has honored Troy Arnold, Partner at Echo Health Advisors, as one of its 2026 Emerging Leaders, 50 corporate venture capital executives finding industry-leading success in the mid-stage of their careers. 

Read more

Lantern secures $30M strategic investment from Morgan Health and Echo Health Ventures to help employers reduce costs and improve outcomes for specialty care

Lantern, the leading Specialty Care Platform serving 12 million people across the U.S., today announced a $30 million investment led by Morgan Health – a division of JPMorganChase dedicated to improving employer-sponsored healthcare – and Echo Health Ventures, a strategic investment platform investing on behalf of multiple Blues health plans.

Read more
Avalon logo

Avalon Healthcare Solutions announces strategic investment to accelerate the future of diagnostic intelligence

Avalon Healthcare Solutions today announced a new majority investment from WindRose Health Investors, with continued support from existing investor Francisco Partners.

Read more

Codoxo’s oversubscribed Series C to revolutionize payment integrity for America’s largest health plans

Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures.

Read more

Heartbeat Health CEO and Echo advisor talk health care trends and cardiology on Regence podcast

Echo Health Ventures advisor Dr. Lisa Bielamowicz and Dr. Jeff Wessler, CEO of Echo portfolio company Heartbeat Health, discussed health care trends and cardiology innovation, respectively, on recent episodes of the Regence HealthChangers podcast. The HealthChangers podcast is produced by Regence health plans, whose parent company is Echo founding partner Cambia Health Solutions. In his…

Read more

$97M Series D backed by strategic investors across the oncology ecosystem positions Thyme Care to break through cancer care’s biggest bottlenecks

Thyme Care, the leading value-based cancer care enabler, today announced a $97M Series D fundraise from current investors CVS Health® Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures.

Read more

RevSpring to acquire Kyruus Health, creating a connected care journey from search to final payment

RevSpring, a Frazier Healthcare portfolio company, is pleased to announce that it has entered into a definitive agreement to acquire Kyruus Health, a pioneer in provider data, search, and scheduling.

Read more

Truven acquires Springbuk to help employers make better, faster healthcare decisions

Truven by Merative, a leading portfolio of healthcare analytics and real-world data solutions, has acquired Springbuk, a leading health intelligence platform for employers and their advisors.

Read more
Strive Health logo

Strive Health raises $550 Million in Series D funding

Strive Health, the national leader in value-based kidney care, raised $300 million in a Series D equity round and secured $250 million in debt financing for a combined $550 million capital raise.

Read more

EVERSANA merges with Waltz Health to create a new force in pharma commercialization and prescription drug access

EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access.

Read more